All Stories

  1. Radiomolecular Therapy of Neuroendocrine Character, Positive for sst2 Receptor Hepatocellular Malignancies

    Article • March 2022, Bentham Science Publishers

    GEORGIOS LYMOURIS

  2. Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series

    Article • BMC Psychiatry, June 2021, Springer Science + Business Media

    GEORGIOS LYMOURIS

  3. Liver Intra-arterial PRRT with 111In-Octreotide

    Article • January 2021, Springer Science + Business Media

    GEORGIOS LYMOURIS

  4. Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases

    Article • Clinical Nuclear Medicine, March 2016, Wolters Kluwer Health

    Professor Georgios P. Fragulidis, GEORGIOS LYMOURIS

  5. Radionuclide Therapy of Painful Bone Metastases—A Comparative Study Between Consecutive Radionuclide Infusions, Combination With Chemotherapy, and Radionuclide Infusions Alone

    Article • American Journal of Hospice and Palliative Medicine®, December 2012, SAGE Publications

    GEORGIOS LYMOURIS

  6. Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis

    Article • Journal of the Neurological Sciences, February 2012, Elsevier

    GEORGIOS LYMOURIS

  7. Neuroendocrine Tumors: A Focus on Liver Metastatic Lesions

    Article • Frontiers in Oncology, January 2012, Frontiers

    GEORGIOS LYMOURIS

  8. Increased Breast Density Correlates with the Proliferation-Seeking Radiotracer 99mTc(V)-DMSA Uptake in Florid Epithelial Hyperplasia and in Mixed Ductal Carcinoma in Situ with Invasive Ductal Carcinoma but Not in Pure Invasive Ductal Carcino...

    Article • Molecular Imaging, September 2011, SAGE Publications

    GEORGIOS LYMOURIS

  9. Clinical and imaging correlations of bone turnover markers in prostate cancer patients with bone only metastases

    Article • Nuclear Medicine Communications, March 2010, Wolters Kluwer Health

    GEORGIOS LYMOURIS

  10. Patient specific computer automated dosimetry calculations during therapy with 111In Octreotide

    Article • European Journal of Radiography, December 2009, Elsevier

    GEORGIOS LYMOURIS

  11. Severe dopaminergic pathways damage in a case of chronic toluene abuse

    Article • Clinical Neurology and Neurosurgery, December 2009, Elsevier

    GEORGIOS LYMOURIS

  12. Patient specific computer automated dosimetry calculations during therapy with <sup>111</sup>In octreotide

    Article • November 2009, Institute of Electrical & Electronics Engineers (IEEE)

    GEORGIOS LYMOURIS

  13. Predictive value of the clinically and scintigraphically important bone lesions in hormone-refractory prostate cancer (HRPC)

    Article • Revista de Oncología, November 2009, Springer Science + Business Media

    GEORGIOS LYMOURIS

  14. Management of Metastatic Bone Pain with Repeated Doses of Rhenium 186-HEDP in Patients Under Therapy with Zoledronic Acid: A Safe and Additively Effective Practice

    Article • Cancer Biotherapy & Radiopharmaceuticals, October 2009, Mary Ann Liebert Inc

    GEORGIOS LYMOURIS

  15. Predictive implications of bone turnover markers after palliative treatment with 186Re-HEDP in hormone-refractory prostate cancer patients with painful osseous metastases

    Article • European Journal of Pediatrics, August 2009, Springer Science + Business Media

    GEORGIOS LYMOURIS

  16. Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases

    Article • European Journal of Pediatrics, June 2008, Springer Science + Business Media

    GEORGIOS LYMOURIS

  17. Optimization of doses received by the hospital staff and the members of the family of patients undergoing 111In-DTPA-D-Phe1-Octreotide therapy

    Article • Radiation Protection Dosimetry, December 2006, Oxford University Press (OUP)

    GEORGIOS LYMOURIS

  18. Evaluation of the Therapeutic Response to In-111-DTPA Octreotide-Based Targeted Therapy in Liver Metastatic Neuroendocrine Tumors According to CT/MRI/US Findings

    Article • Cancer Biotherapy & Radiopharmaceuticals, April 2005, Mary Ann Liebert Inc

    GEORGIOS LYMOURIS

  19. Isolated Talus Metastasis from Breast Carcinoma: A Case Report and Review of the Literature

    Article • Oncology Research and Treatment, January 2005, Karger Publishers

    GEORGIOS LYMOURIS

  20. Imaging and localization of pancreatic insulinomas

    Article • Clinical Imaging, July 2001, Elsevier

    GEORGIOS LYMOURIS

  21. Pentavalent rhenium-188 dimercaptosuccinic acid: a new kit formulation and its initial evaluation in mice

    Article • Radiochimica Acta, February 2001, De Gruyter

    GEORGIOS LYMOURIS

  22. Receptor Scintigraphy of Non-Neuroendocrine Cancers with In-111 Pentetreotide

    Article • Hybridoma, February 1997, Mary Ann Liebert Inc

    GEORGIOS LYMOURIS

  23. Untersuchungen zur Biokinetik tumoraffiner Yttrium-Zubereitungen -1. Teil

    Article • Nuklearmedizin - NuclearMedicine, January 1995, Thieme Publishing Group

    GEORGIOS LYMOURIS

  24. Untersuchung zur Biokinetik tumoraffiner Yttrium-Zubereitungen - 2. Teil

    Article • Nuklearmedizin - NuclearMedicine, January 1995, Thieme Publishing Group

    GEORGIOS LYMOURIS

  25. Der Einfluß von knochenaffinen Metallsalzen auf die Bioverteilung tumoraffiner Schwermetallkomplexe

    Article • Nuklearmedizin - NuclearMedicine, January 1993, Thieme Publishing Group

    GEORGIOS LYMOURIS

  26. Langzeitbiokinetik des 169Yb nach Injektion als Zitrat, Hydroxyethylethylen- diamintetraazetat und Nitrilotriazetat

    Article • Nuklearmedizin - NuclearMedicine, January 1993, Thieme Publishing Group

    GEORGIOS LYMOURIS

  27. Der Einfluß von Ethylendiamin- tetramethylenphosphonat auf die Bioverteilung tumoraffiner Radionuklide

    Article • Nuklearmedizin - NuclearMedicine, January 1993, Thieme Publishing Group

    GEORGIOS LYMOURIS

  28. Thalassemic osteoarthropathy treated by radiotherapy

    Article • Radiotherapy and Oncology, June 1992, Elsevier

    GEORGIOS LYMOURIS

  29. Der Einfluß von Ca-Diethylentriaminpentaacetat auf das Bioverhalten tumoraffiner Metallkomplexe

    Article • Nuklearmedizin - NuclearMedicine, January 1992, Thieme Publishing Group

    GEORGIOS LYMOURIS

  30. Heterogeneity of Duodenal Ulcer as Suggested by Differences in Gastrin Response to a Protein Meal

    Article • Annals of the New York Academy of Sciences, May 1986, Wiley

    GEORGIOS LYMOURIS

  31. Protein meal and gastrin levels

    Article • Nuclear Medicine Communications, February 1986, Wolters Kluwer Health

    GEORGIOS LYMOURIS